Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1990-05-17
1993-03-09
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 514885, A61K 3156
Patent
active
051927551
ABSTRACT:
The invention provides novel pregnane derivatives having the formula: ##STR1## wherein X=F, Cl or Br; R.sub.1 =F or Cl; R.sub.2 =H(.beta.OH) or O; R.sub.3 =alkyl(1-4 C); R.sub.4 =alkyl(1-4 C); and the dotted line indicates the optional presence of a double bond.
The novel compounds have been found to possess immunomodulating properties.
REFERENCES:
patent: 3162630 (1964-12-01), Morand
patent: 3483236 (1969-12-01), Schaub
patent: 3520908 (1970-07-01), Hewett et al.
patent: 3531503 (1970-09-01), Cereghetti et al.
patent: 4678609 (1987-07-01), Engels
patent: 4839282 (1989-06-01), Weber et al.
Steroid Reactions (1963), p. 202; Djerassi.
Chemical Abstracts, Abstract No. 47795p, vol. 78, p. 278 (Feb. 1973).
Max Samter, M.D., Editor, Immunological Diseases, "86. Pharmacological Immunosuppression", vol. II, pp. 1522-1533 (1978).
Logan Robert T.
Woods Gilbert F.
Akzo N.V.
Jordon Kimberly R.
Waddell Frederick E.
LandOfFree
Pregnane derivatives as immunomodulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pregnane derivatives as immunomodulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pregnane derivatives as immunomodulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-211576